Rakuten Investment Management Inc. Buys New Position in HCA Healthcare, Inc. $HCA

Key Points

• Rakuten Investment Management acquired 25,469 shares of HCA Healthcare in the second quarter, valued at approximately $9.99 million. Institutional and hedge-fund investors collectively own 62.73% of the company.
• HCA Healthcare exceeded quarterly expectations, reporting adjusted earnings of $7.59 per share and revenue of $20.23 billion, with revenue up 8.7% year over year.
• The company declared a quarterly dividend of $0.78 per share, representing an annualized payout of $3.12 and a 0.7% yield. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $462.64.

Rakuten Investment Management Inc. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 25,469 shares of the company's stock, valued at approximately $9,992,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $5,069,974,000. State Street Corp lifted its position in HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company's stock worth $3,532,563,000 after acquiring an additional 76,039 shares during the period. Capital World Investors increased its holdings in shares of HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company's stock valued at $2,334,040,000 after purchasing an additional 40,086 shares during the period. Geode Capital Management LLC raised its stake in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company's stock worth $1,702,738,000 after purchasing an additional 13,565 shares during the last quarter. Finally, Norges Bank purchased a new position in HCA Healthcare in the 4th quarter valued at $1,262,513,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 0.4%

HCA opened at $417.57 on Friday. The firm has a market cap of $90.40 billion, a P/E ratio of 13.98, a PEG ratio of 1.45 and a beta of 1.10. The business's fifty day simple moving average is $401.08 and its 200 day simple moving average is $441.46. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the previous year, the firm posted $6.84 earnings per share. The company's quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities analysts expect that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is 10.45%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on HCA shares. Weiss Ratings downgraded shares of HCA Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, June 9th. Robert W. Baird reduced their price objective on shares of HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating for the company in a research report on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 target price on HCA Healthcare in a research report on Monday, July 27th. Wall Street Zen downgraded HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, May 2nd. Finally, Jefferies Financial Group set a $450.00 target price on HCA Healthcare in a report on Tuesday, July 14th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source